Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel
ter Braak, B Siezen, CLE Kannegieter, N Koedoot, E van de Water, B van der Laan, JW
ter Braak, B
Siezen, CLE
Kannegieter, N
Koedoot, E
van de Water, B
van der Laan, JW
Series / Report no.
Open Access
Type
Article
Language
Date
2014
Research Projects
Organizational Units
Journal Issue
Title
Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel
Translated Title
Published in
Arch Toxicol 2014; 88(4):953-66